Skip to content

Study · Non-randomized trial · n = 116 · 1989

2 results

[The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].

Ivanova LA

Vrachebnoe delo1 Oct 1989

PMID2617987 (opens in a new tab)PepBankPUB-02617987
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In pulmonary tuberculosis patients, thymalin added early to chemotherapy increased treatment efficacy earlier than control treatment.

    In plain wordsIn tuberculosis patients, thymalin with chemotherapy improved treatment efficacy earlier than control treatment.

    Peptide
    Thymalin
    Outcome
    IncreaseTreatment efficacy
    Study

    n = 116

    Comparator
    Control group
    Outcome group
    Infection and antimicrobial activity · Respiratory
    Studied dose
    Dose not stated

    Source sentences

    Summary
    It is shown that immunochemotherapy allows to increase the treatment efficacy earlier with a parallel restoration of cellular immunity indices.
    3 context sentences
    Summary · context
    Results are reported of the treatment of 116 patients with a control group pulmonary tuberculosis.
    Summary · context
    Patients of the main group (76 persons) received thymalin at the early stages of chemotherapy.
    Summary · context
    Results were compared with a control group.
  2. 02HumanNon-randomized trialEfficacy outcome

    In pulmonary tuberculosis patients, thymalin with chemotherapy restored cellular immunity indices compared with control treatment.

    In plain wordsIn tuberculosis patients, thymalin with chemotherapy restored cellular immune measures compared with control treatment.

    Peptide
    Thymalin
    Outcome
    IncreaseCellular immunity indices
    Study

    n = 116

    Comparator
    Control group
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    It is shown that immunochemotherapy allows to increase the treatment efficacy earlier with a parallel restoration of cellular immunity indices.
    3 context sentences
    Summary · context
    Results are reported of the treatment of 116 patients with a control group pulmonary tuberculosis.
    Summary · context
    Patients of the main group (76 persons) received thymalin at the early stages of chemotherapy.
    Summary · context
    Results were compared with a control group.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.